Loading organizations...
Loading organizations...
Develops GPCR antibody therapeutics for various medical needs.
Gmax Biopharm has raised $78.0M across 1 funding round.
Gmax Biopharm has raised $78.0M in total across 1 funding round.
Gmax Biopharm has raised $78.0M in total across 1 funding round.
Gmax Biopharm's investors include China Merchants Group.
Gmax Biopharm has raised $78.0M across 1 funding round. Most recently, it raised $78.0M Series C in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 9, 2021 | $78.0M Series C | China Merchants Group |